Mohawk Industries, Inc. Invites You to Join the Second Quarter 2022 Earnings Conference Call

Written by Customer Service on July 7, 2022. Posted in Public Companies.

CALHOUN, Ga., July 07, 2022 (GLOBE NEWSWIRE) — In conjunction with Mohawk Industries, Inc. (NYSE: MHK) Second Quarter 2022 earnings release on Thursday July 28, 2022 you are invited to listen to its conference call that will be broadcast live on Friday July 29, 2022 at 11:00 am ET. What: Mohawk Industries, Inc. 2nd Quarter 2022 Earnings Call When: July 29, 2022 11:00 am ET Where: www.mohawkind.com Select Investor Information How: Live over the Internet – Simply log on to the web at the address above or Register for the conference call at https://dpregister.com/sreg/10168983/f39af04a6f Live Conference Call: Dial 1-866-777-2509 (US/Canada) Dial 1-412-317-5413 (Int’l) Mohawk Industries is the leading global flooring manufacturer that creates products...

Scorpio Tankers Announces Repurchases of Its Common Shares and Its Convertible Notes, and the Exercise of Purchase Options on Six Leased Vessels

Written by Customer Service on July 7, 2022. Posted in Public Companies.

MONACO, July 07, 2022 (GLOBE NEWSWIRE) — Scorpio Tankers Inc. (NYSE:STNG) (“Scorpio Tankers,” or the “Company”) announced that the Company has repurchased its common shares and convertible notes due 2025, and the Company has given notice to exercise its purchase options on six leased vessels. Repurchase of Common Shares Scorpio Tankers has recently repurchased 364,474 of its common shares in the open market at an average price of $29.17 per share. Repurchase of Convertible Notes Due 2025 The Company has recently repurchased $1.5 million in aggregate principal amount of its Convertible Notes due 2025 in the open market. Securities Repurchase Program As of the date of this press release, the Company has $223.4 million available under its Securities Repurchase Program. The Company’s securities include its common shares, Senior...

Flywire to Announce Second Quarter 2022 Results on August 9, 2022

Written by Customer Service on July 7, 2022. Posted in Public Companies.

BOSTON, July 07, 2022 (GLOBE NEWSWIRE) — Flywire Corporation (Nasdaq: FLYW) a global payments enablement and software company, today announced that its second quarter 2022 financial results will be released after market close on Tuesday, August 9, 2022. Flywire will host a conference call to discuss its second quarter 2022 financial results at 5:00pm ET the same day. Hosting the call will be Mike Massaro, CEO, Rob Orgel, President and COO, and Mike Ellis, CFO. The conference call will be webcast live from Flywire’s investor relations website at https://ir.flywire.com/. A replay will be available on the investor relations website following the call. About Flywire Flywire is a global payments enablement and software company. Flywire combines its proprietary global payments network, next-gen payments platform and vertical-specific...

Avis Budget Group To Announce Second Quarter 2022 Results on August 1st

Written by Customer Service on July 7, 2022. Posted in Earnings Releases And Operating Results.

Conference Call to Discuss Results Scheduled for August 2nd, 2022 PARSIPPANY, N.J., July 07, 2022 (GLOBE NEWSWIRE) — Avis Budget Group, Inc. (NASDAQ: CAR) announced today that it plans to report its second quarter 2022 results after the market close on Monday, August 1st, 2022, and to host a conference call for institutional investors to discuss these results on Tuesday, August 2nd, 2022 at 8:30 a.m. Eastern time. Investors may access the call at ir.avisbudgetgroup.com, or by dialing (877)-407-2991. Investors are encouraged to dial in approximately 10 minutes prior to the call. A web replay will be available at ir.avisbudgetgroup.com following the call. A telephone replay will be available from 11:00 a.m. Eastern time on August 2nd, 2022 until 10:00 p.m. on August 16th, 2022 at (877)-660-6853 using conference code 13730889. About...

Mettler-Toledo International Inc. to Host Second Quarter 2022 Earnings Conference Call

Written by Customer Service on July 7, 2022. Posted in Earnings Releases And Operating Results.

COLUMBUS, Ohio, July 07, 2022 (GLOBE NEWSWIRE) — Mettler-Toledo International Inc. (NYSE:MTD) today announced it will host a conference call to discuss the Company’s quarterly results on Friday, July 29, 2022 at 7:00 a.m. Eastern Time. To hear a live webcast of the call, visit www.mt.com/investors on the Company’s website. A replay of the webcast will be available until August 5, 2022. METTLER TOLEDO (NYSE: MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control, and manufacturing processes for customers in a wide range of industries including life sciences,...

Inotiv, Inc. Expands Protein/Peptide Bioanalytical Capabilities with Acquisition of Protypia, Inc.

Written by Customer Service on July 7, 2022. Posted in Mergers And Acquisitions.

WEST LAFAYETTE, Ind., July 07, 2022 (GLOBE NEWSWIRE) — Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that the Company has completed the purchase of Nashville, Tennessee based Protypia, Inc. (“Protypia”). Protypia is an emerging protein/peptide bioanalytical company offering high-quality, targeted tissue-based protein and peptide mass spectrometry. “The addition of Protypia’s quantitative tissue-based large molecule bioanalytical capabilities to Inotiv’s already established mass spectrometry-based bioanalytical offerings will enable clients to translate their clinical findings back into their discovery and preclinical...

Nurix Therapeutics Reports Fiscal Second Quarter 2022 Financial Results and Provides a Corporate Update

Written by Customer Service on July 7, 2022. Posted in Earnings Releases And Operating Results.

NX-2127 advanced to Phase 1b in CLL based on promising data in Phase 1a clinical trial First patient dosed in NX-5948 Phase 1a clinical trial for certain B-cell malignancies NX-1607 IND cleared FDA for expansion of enrollment to U.S. clinical sites for patients with solid tumors Research engine achieved collaboration milestone for fifth consecutive quarter Strong financial position with $348.8 million in cash and investments as of May 31, 2022 SAN FRANCISCO, July 07, 2022 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs, today reported financial results for the second quarter ended May 31, 2022 and provided a corporate update. “In the second quarter of 2022, we reported promising data in our Phase 1 trial of NX-2127 with clinical...

Kura Sushi USA Announces Fiscal Third Quarter 2022 Financial Results

Written by Customer Service on July 7, 2022. Posted in Earnings Releases And Operating Results.

IRVINE, Calif., July 07, 2022 (GLOBE NEWSWIRE) — Kura Sushi USA, Inc. (“Kura Sushi” or the “Company”) (NASDAQ: KRUS), a technology-enabled Japanese restaurant concept, today reported fiscal third quarter 2022 financial results for the period ended May 31, 2022. Fiscal Third Quarter 2022 Highlights Total sales were $38.0 million, compared to $18.5 million in the third quarter of 2021; Comparable restaurant sales increased 65% for the third quarter of 2022 as compared to the third quarter of 2021; Operating income was $0.5 million, compared to operating income of $0.9 million in the third quarter of 2021; Net income was $0.5 million, or $0.05 per diluted share, compared to net income of $0.8 million, or $0.09 per diluted share, in the third quarter of 2021; Adjusted net income* was $0.5 million, or $0.05 per diluted share, compared...

Inventiva announces the screening of the first patient in LEGEND, a Phase IIa combination trial with lanifibranor and empagliflozin in patients with NASH and T2D

Written by Customer Service on July 7, 2022. Posted in Public Companies.

The Phase IIa Proof-of-Concept study is designed to assess the safety and efficacy of lanifibranor in combination with the SGLT2 inhibitor empagliflozin for the treatment of patients with non-cirrhotic non-alcoholic steatohepatitis (NASH) and type-2 diabetes (T2D) The primary efficacy endpoint will be based on improvement in HbA1c Secondary efficacy endpoints include changes in liver enzymes, markers of glycemic control, lipid metabolism, inflammation and body fat composition Publication of topline results is expected in the second half of 2023 Daix (France), Long Island City (New York, United States), July 7, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of NASH and other diseases with significant unmet medical...

Hudbay to Host Conference Call for Second Quarter 2022 Results

Written by Customer Service on July 7, 2022. Posted in Public Companies.

TORONTO, July 07, 2022 (GLOBE NEWSWIRE) — Hudbay Minerals Inc. (“Hudbay” or the “company”) (TSX, NYSE: HBM) senior management will host a conference call on Tuesday, August 9, 2022 at 8:30 a.m. ET to discuss the company’s second quarter 2022 results. Second Quarter 2022 Results Conference Call and Webcast Date: Tuesday, August 9, 2022 Time: 8:30 a.m. ET Webcast: www.hudbay.com Dial in: 1-416-915-3239 or 1-800-319-4610 Hudbay plans to issue a news release containing the second quarter 2022 results on Monday, August 8, 2022 and post it on the company’s website. An archived audio webcast of the call also will be available on Hudbay’s website. About Hudbay Hudbay (TSX, NYSE: HBM) is a diversified mining company primarily producing copper concentrate (containing copper, gold and silver), zinc metal and silver/gold doré....

Day: July 7, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice